Article
MTHFR A1298C polymorphisms reduce the risk of congenital heart defects: a meta-analysis from 16 case-control studies.
Italian journal of pediatrics - 4 Dec 2017
Yu Di, Zhuang Zhulun, Wen Zhongyuan, Zang Xiaodong, Mo Xuming
Abstract excerpt
BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in the hyperhomocysteinemia, which is a risk factor related to the occurrence of congenital heart defect (CHD). However, the association between MTHFR polymorphism and CHD has been inconclusive. METHODS: We conducted an updated meta-analysis to provide comprehensive evidence on the role of MTHFR A1298C polymorphism in CHD. Databases were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
